CIK 0001999480 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Alto Neuroscience, Inc.
Sign in to watch- Ticker
- ANRO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 834210124
- Phone
- 773-255-5012
- Business address
- 650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW, CA, 94041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,567,247
- in 1 filing
Net −$3,567,247. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-03 | Savitz Adam CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +123,645 | 123,645 | ||
| 2025-07-03 | Savitz Adam CHIEF MEDICAL OFFICER | Returned to the company · Employee Stock Option (Right to Buy) | −123,645 | 0 | ||
| 2025-07-03 | Savitz Adam CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +73,000 | 73,000 | ||
| 2025-07-03 | Savitz Adam CHIEF MEDICAL OFFICER | Returned to the company · Employee Stock Option (Right to Buy) | −73,000 | 0 | ||
| 2025-07-03 | Savitz Adam CHIEF MEDICAL OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +76,000 | 76,000 | ||
| 2025-07-03 | Savitz Adam CHIEF MEDICAL OFFICER | Returned to the company · Employee Stock Option (Right to Buy) | −76,000 | 0 | ||
| 2025-07-03 | Etkin Amit PRESIDENT AND CEO | Grant or award · Employee Stock Option (Right to Buy) | +34,620 | 34,620 | ||
| 2025-07-03 | Etkin Amit PRESIDENT AND CEO | Returned to the company · Employee Stock Option (Right to Buy) | −34,620 | 0 | ||
| 2025-07-03 | Etkin Amit PRESIDENT AND CEO | Grant or award · Employee Stock Option (Right to Buy) | +247,290 | 247,290 | ||
| 2025-07-03 | Etkin Amit PRESIDENT AND CEO | Returned to the company · Employee Stock Option (Right to Buy) | −247,290 | 0 | ||
| 2025-07-03 | Etkin Amit PRESIDENT AND CEO | Grant or award · Employee Stock Option (Right to Buy) | +223,000 | 223,000 | ||
| 2025-07-03 | Etkin Amit PRESIDENT AND CEO | Returned to the company · Employee Stock Option (Right to Buy) | −223,000 | 0 | ||
| 2025-07-03 | Etkin Amit PRESIDENT AND CEO | Grant or award · Employee Stock Option (Right to Buy) | +215,000 | 215,000 | ||
| 2025-07-03 | Etkin Amit PRESIDENT AND CEO | Returned to the company · Employee Stock Option (Right to Buy) | −215,000 | 0 | ||
| 2025-07-03 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER & CBO | Grant or award · Employee Stock Option (Right to Buy) | +44,962 | 44,962 | ||
| 2025-07-03 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER & CBO | Returned to the company · Employee Stock Option (Right to Buy) | −44,962 | 0 | ||
| 2025-07-03 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER & CBO | Grant or award · Employee Stock Option (Right to Buy) | +33,833 | 33,833 | ||
| 2025-07-03 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER & CBO | Returned to the company · Employee Stock Option (Right to Buy) | −33,833 | 0 | ||
| 2025-07-03 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER & CBO | Grant or award · Employee Stock Option (Right to Buy) | +202,329 | 202,329 | ||
| 2025-07-03 | Smith Nicholas Conrad CHIEF FINANCIAL OFFICER & CBO | Returned to the company · Employee Stock Option (Right to Buy) | −202,329 | 0 |
Page 3 of 7 · 125 trades